亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Clinical status of hospitalized keloid cases from 2013 to 2018

医学 瘢痕疙瘩 疤痕 外科 皮肤病科 梅德林 临床实习 年轻人 重症监护医学 三级护理
作者
Zhe Zhu,Weishi Kong,Haibo Wang,Yongqiang Xiao,Ying Shi,Lanxia Gan,Yu Sun,Hongtai Tang,Zhaofan Xia
出处
期刊:Burns [Elsevier BV]
卷期号:48 (8): 1874-1884 被引量:16
标识
DOI:10.1016/j.burns.2021.12.007
摘要

Keloids are intractable scar diseases and sometimes undergo hospitalization. This study aims to represent current status of keloid management in a national sample of hospitalized scar cases.Data of scar-diagnosed cases admitted in 1064 China's tertiary hospitals between 2013 and 2018, were obtained from the Hospital Quality Monitoring System (HQMS) database. Variables analyzed include sex, age, nationality, occupation, hospital department, accompanied symptoms at admission, surgical treatment, length of stay (LOS), and hospitalization cost. The potential risk factors of keloid diagnosis among scar cases were preliminarily identified through the Cochran-Mantel-Haenszel tests and univariate regression analyses.This study identified 177,586 scar cases including 21,777 keloid cases and 155,809 non-keloid scar cases. The prevalence of scars in the HQMS database was gradually decreased from 0.123% in 2013 to 0.075% in 2018. We found a preponderances of males (54.32%), adults (61.52%), Han nationality (93.38%), and students (17.35%) in scar cases, among whom keloid cases accounted for growing proportions increasing from 9.2% in 2013 to 15.1% in 2018. Comparing non-keloid scar cases, keloid cases consisted of more women (59.1% VS 43.8%), office staffs (13.08% VS 6.75%) and retirees (5.16% VS 2.65%), and less Zhuang (0.79% VS 1.40%) and Hui nationalities (0.76% VS 1.00%), and showed lower incidence of accompanied symptoms (4.51% VS 47.96%) and higher rate of receiving operations (57.96% VS 50.28%, P < 0.001). Both the LOS and cost per hospitalization were lower in keloid cases. Furthermore, the adult and older women, Han and Uyghur nationalities, office staffs and retirees, and admitted in otolaryngology and dermatology departments, were potential predictors of keloid diagnosis among hospitalized scar cases.When viewed at the national level, keloid occupies an important part in scar management in Chinese tertiary hospitals. Demographic and clinical differences between keloids and other scars facilitate understanding and promoting of individualized anti-scar therapeutic strategies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
正直的松鼠完成签到 ,获得积分10
13秒前
孙老师完成签到 ,获得积分10
38秒前
浮游应助科研通管家采纳,获得10
53秒前
量子星尘发布了新的文献求助10
1分钟前
卜哥完成签到,获得积分10
1分钟前
Crazybow5完成签到,获得积分10
2分钟前
光亮静槐完成签到 ,获得积分10
2分钟前
2分钟前
重庆森林发布了新的文献求助10
2分钟前
英姑应助勤恳依霜采纳,获得10
2分钟前
单薄的蓝天完成签到,获得积分10
2分钟前
CipherSage应助科研通管家采纳,获得10
2分钟前
浮游应助科研通管家采纳,获得10
2分钟前
2分钟前
大模型应助重庆森林采纳,获得10
2分钟前
John完成签到,获得积分10
3分钟前
独孤家驹完成签到 ,获得积分10
4分钟前
冷傲迎梅完成签到 ,获得积分10
4分钟前
balko发布了新的文献求助10
4分钟前
科目三应助科研通管家采纳,获得10
4分钟前
浮游应助科研通管家采纳,获得10
4分钟前
浮游应助科研通管家采纳,获得10
4分钟前
4分钟前
小二郎应助johnzsin采纳,获得10
4分钟前
5分钟前
苗苗应助balko采纳,获得10
5分钟前
6分钟前
6分钟前
johnzsin发布了新的文献求助10
6分钟前
外向的妍完成签到,获得积分10
6分钟前
6分钟前
浮游应助科研通管家采纳,获得10
6分钟前
咯咯咯完成签到 ,获得积分10
6分钟前
www完成签到,获得积分10
8分钟前
浮游应助科研通管家采纳,获得10
8分钟前
浮游应助科研通管家采纳,获得10
8分钟前
赘婿应助科研通管家采纳,获得10
8分钟前
星辰大海应助科研通管家采纳,获得10
8分钟前
浮游应助科研通管家采纳,获得10
8分钟前
www完成签到 ,获得积分10
9分钟前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
TOWARD A HISTORY OF THE PALEOZOIC ASTEROIDEA (ECHINODERMATA) 1000
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
The Social Work Ethics Casebook(2nd,Frederic G. R) 600
Handbook of Social and Emotional Learning 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5116587
求助须知:如何正确求助?哪些是违规求助? 4323211
关于积分的说明 13469976
捐赠科研通 4155574
什么是DOI,文献DOI怎么找? 2277377
邀请新用户注册赠送积分活动 1279208
关于科研通互助平台的介绍 1217236